Dave Vivek Pravin, Pappuru Rajeev R
Vitreoretina Services, Netra Mandir Eye Institute, Mumbai, Maharashtra, India.
Indian J Ophthalmol. 2016 Jan;64(1):87-8. doi: 10.4103/0301-4738.178143.
A 62-year-old hypertensive male presented with acute nonarteritic ischemic optic neuropathy (NAION) with contiguous macular edema and subretinal fluid in the right eye. Presenting vision was 20/1000. The patient was treated with intravitreal bevacizumab 1.25 mg/0.05 ml. At 1 month follow-up, the macular edema and the optic nerve head edema completely resolved with a good visual improvement up to 20/40. The visual improvement was maintained at the last follow-up 6 months postinjection. Intravitreal bevacizumab may be a good option for acute NAION especially in an unusual presentation with macular edema and subretinal fluid.
一名62岁的高血压男性患者,右眼出现急性非动脉炎性缺血性视神经病变(NAION),伴有相邻的黄斑水肿和视网膜下液。就诊时视力为20/1000。患者接受了玻璃体内注射1.25 mg/0.05 ml贝伐单抗治疗。在1个月的随访中,黄斑水肿和视神经乳头水肿完全消退,视力显著改善至20/40。在注射后6个月的最后一次随访中,视力改善情况得以维持。玻璃体内注射贝伐单抗可能是急性NAION的一种良好治疗选择,尤其是在伴有黄斑水肿和视网膜下液这种不寻常表现的情况下。